Exosens EXENS.PA
FranceIndustrials · Aerospace & DefenseEuronext París · EUR
69.70 EUR (+24.5%)
10 analysts
Trading 2120.00 €Open account ↗
XTB0.00 €affiliateOpen account ↗
eToro0.86 €Open account ↗XTB0.00 €★ featured · affiliateOpen account ↗Trading 2120.00 €Open account ↗eToro0.86 €Open account ↗XTB0.00 €★ featured · affiliateOpen account ↗200.00 € order · cheapest cheapest available in your country iCompare all 22 brokers →What does it do?
Exosens is a French technology company that designs and manufactures image sensors, photodetectors, and vision systems for defense, security, and industrial and medical applications.
Listed on Euronext París · Symbol EXENS.PA · EPA: EXENS · Currency EUR
Key points
from its scores- ✓Good share-price trend8.0
- ✕Demanding valuation2.3
- ✕Little or no dividend4.1
- ✕Weak growth4.2
AI analysis
bottom line, main risk, context and newsThe defense business has structural tailwinds, but the valuation already discounts an earnings recovery that has not yet materialized; wait for cash conversion and profit to improve before adding to the position.
Exosens presents a mixed profile: revenue growth of 15.30% and a gross margin of 60.13% show a business with solid demand, but the -45.10% drop in profit and a demanding valuation (P/E 133.33, EV/EBITDA 29.09) weigh on its attractiveness. The balance sheet is sound (Net Debt/EBITDA 1.91) and momentum is strong (26.71% over 12 months), but the 28.04% free cash flow conversion and the 76.63% payout ratio limit financial flexibility.
The -45.10% drop in profit and weak free cash flow conversion (28.04%) suggest that revenue growth is not translating into profitability; if the margin recovery does not arrive, the current valuation (P/E 133.33) is unsustainable.
Context and risks
Exosens has no material exposure to current macro factors: its business of sensors and vision systems for defense and industrial applications does not depend on interest rates, oil prices, or conflict shipping routes. Its net debt is moderate (Net Debt/EBITDA of 1.91) and its activity is tied to European defense demand, not commodity cycles.
Is Exosens stock cheap or expensive?
at the analysis dateOn P/E and EV / EBITDA, it trades 263% above the Industrials median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 133.3 | 25.4 | +424% |
| EV / EBITDA | 29.1 | 14.5 | +101% |
| Price / book | 6.3 | 4.1 | +56% |
| Price / sales | 5.7 | 2.1 | +176% |
Sector: median of the 388 Industrials companies analysed. In bold, the multiples used for the comparison.
Valuation score: 2.3 out of 10 (median for Industrials: 5.0).
Average analyst target: 69.70 EUR, +24.5% versus the price.
A premium can be justified if the company is of higher quality or grows faster than its sector: Quality / Moat 5.4 (sector 5.8), Growth 4.2 (sector 6.6).
Classic formulas with standard assumptions (10.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Industrials medianValuation
- P/E
- 133.3
- Forward P/E
- 23.2
- EV / EBITDA
- 29.1
- Price / book
- 6.3
- Price / sales
- 5.7
- Market cap
- 2.9B EUR
- Enterprise value
- 3.1B EUR
Profitability
- ROE
- 12.7%
- ROA
- 6.2%
- ROIC (approx.)
- 9.0%
- Gross margin
- 60.1%
- Operating margin
- 12.9%
- Net margin
- 6.0%
- Free cash flow
- 29.4M EUR
- FCF yield
- 1.0%
- Cash conversion
- 28%
Solvency
- Total debt
- 269.5M EUR
- Net debt
- 200.2M EUR
- Cash
- 69.2M EUR
- EBITDA
- 104.9M EUR
- Net debt / EBITDA
- 1.91
- Debt / equity
- 59.77
- Current ratio
- 2.35
- Quick ratio
- 1.32
Growth
- Revenue growth
- +15.3%
- Earnings growth
- −45.1%
- EPS (TTM)
- 0.42 EUR
- EPS (forward)
- 2.41 EUR
Dividend
- Dividend yield
- 0.5%
- Payout
- 76.6%
Risk and market
- Beta
- 0.81
- Analyst consensus
- Buy (10)
- Target price
- 69.70 EUR
- 52-week range
- 40.00 – 74.00
Recent news
All EXENS.PA news →Compare it with its sector
All 388 in Industrials →Frequently asked questions about Exosens
Is Exosens stock cheap or expensive?
On P/E and EV / EBITDA, it trades 263% above the Industrials median on average. Valuation score: 2.3 out of 10 (median for Industrials: 5.0). Average analyst target: 69.70 EUR, +24.5% versus the price. This is not investment advice.
What score does Exosens get on MeridIAn Screener?
It scores 5.1 out of 10, rank 1,645 of 2,130 (better than 21% of the companies analysed). Its strongest category is Momentum (8.0) and its weakest, Valuation (2.3). Analysis of 08/10/2026.
What is Exosens's P/E ratio?
Its P/E is 133.3: the share price equals 133.3 times earnings per share over the last 12 months. The Industrials median is 25.4. Based on the earnings analysts expect, the forward P/E is 23.2.
How much is Exosens worth on the stock market?
Its market capitalisation is 2.9B EUR and its enterprise value, debt included, is 3.1B EUR.
How much debt does Exosens have?
Its net debt (debt minus cash) is 200.2M EUR. That is 1.91 times its EBITDA; the Industrials median is 1.58.
Does Exosens pay a dividend?
Yes: its dividend yield is 0.54% and it pays out 77% of its earnings.
How has Exosens stock performed over the last year?
It has risen 29.5% over the last year, excluding dividends. Over the last 52 weeks it has traded between 40.00 and 74.00 EUR. Past performance does not guarantee future results.
What do analysts think of Exosens?
10 analysts cover it; their average recommendation is “Buy” and their average target is 69.70 EUR (+24.5% versus the price). It is an estimate, not market data.